Quarterly report pursuant to Section 13 or 15(d)

Selected Balance Sheet Information

Selected Balance Sheet Information

9 Months Ended

Sep. 30, 2020

4. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)


	September 30,		December 31,
	2020		2019
Prepaid clinical research organizations	$	471	$	48
Prepaid consulting, subscriptions and other expenses		74		134
Prepaid insurances		73		549
Prepaid manufacturing expenses		39		622
Prepaid conferences, travel and other expenses		—		25
Other receivables		—		3

Total	$	657	$	1,381

Amounts prepaid to clinical research organizations (CROs) were classified as current assets. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services.

Property and equipment, net (in thousands)


	September 30,		December 31,
	2020		2019
Computers and office equipment	$	808	$	804
Leasehold improvements		439		439
Software		11		11
		1,258		1,254
Less: accumulated depreciation and amortization		(1,056)		(887)

Total	$	202	$	367

Accrued expenses (in thousands)


	September 30,		December 31,
	2020		2019
Accrued clinical consulting services	$	660	$	684
Accrued vendor payments		309		456
Accrued manufacturing costs		18		635
Other accrued expenses		1		1

Total	$	988	$	1,776

Accrued employee benefits (in thousands)


	September 30,		December 31,
	2020		2019
Accrued bonus expense	$	594	$	858
Accrued vacation expense		158		77

Total	$	752	$	935